Indications for adjuvant radiotherapy in breast cancer Armenian consensus 2021-2022

Author:

Karamyan Nerses1,Ter-Minasyan Vahe2

Affiliation:

1. “IRA Medical Group” Medical Center, Yerevan, Armenia. Department of Oncology, Avdalbekyan National Institute of Health, MoH, RA, Yerevan, Armenia

2. Department of Oncology, Avdalbekyan National Institute of Health, MoH, RA, Yerevan, Armenia

Abstract

The radiotherapy plays a significant role as a component of the complex treatment of breast cancer, in almost all of its stages. However, despite numerous international recommendations and clinical protocols, there is still no single approach among oncologists (surgeons and medical oncologists) referring to radiotherapy (RT). According to our calculations in Armenia, for various reasons, more than 100 primary patients do not receive indicated radiotherapy every year. The main reason for this situation is the lack of approved national clinical protocols that are mandatory for all certified oncological units in the country. In such cases, various professional associations or small initiative groups should play an important role in order to ensure uniform approaches to treatment at the national level. A convenient format for this is to set up small working groups, composed of leading experts in a particular field, who can reach a consensus on the issue under study.

Publisher

National Institute of Health

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3